Evidence map›Paper›PMID 31113495›Full record

ArticleHuman genomics2019

Genetics of heart rate in heart failure patients (GenHRate).

Kaleigh L Evans, Heidi S Wirtz, Jia Li, Ruicong She, Juan Maya, Hongsheng Gui, Andrew Hamer, Christophe Depre, David E Lanfear

Open access · goldAbstract read
In one paragraph

Article in Human genomics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. The genetic landscape of pediatric postural orthostatic tachycardia syndrome.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2025
    Article
  3. Review
  4. Using Omics to Identify Novel Therapeutic Targets in Heart Failure.Circulation. Genomic and precision medicine · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Kaleigh L EvansDepartment of Internal Medicine, Henry Ford Hospital, 2799 West Grand Blvd. K-14, Detroit, MI, 48202, USA.
Heidi S WirtzAmgen Inc, Thousand Oaks, CA, USA.
Jia LiDepartment of Public Health Sciences, Henry Ford Health System, Detroit, MI, USA.
Ruicong SheDepartment of Public Health Sciences, Henry Ford Health System, Detroit, MI, USA.
Juan MayaAmgen Inc, Thousand Oaks, CA, USA.
Hongsheng GuiCenter for Individualized and Genomic Medicine Research, Henry Ford Hospital, Detroit, MI, USA.
Andrew HamerAmgen Inc, Thousand Oaks, CA, USA.
Christophe DepreAmgen Inc, Thousand Oaks, CA, USA.
David E LanfearDepartment of Internal Medicine, Henry Ford Hospital, 2799 West Grand Blvd. K-14, Detroit, MI, 48202, USA. DLANFEA1@hfhs.org.
Amgen (United States) · USHenry Ford Hospital · USHenry Ford Health System · US

Funding

Impact of Race and Genetic Factors on Beta-blocker Effectiveness in Heart FailureR01HL103871 · NHLBI · HENRY FORD HEALTH SYSTEM · PI LANFEAR, DAVID E · 2011 to 2015
$3.5M
Plasma Metabolomics and Myocardial Energetics in Heart FailureR01HL132154 · NHLBI · HENRY FORD HEALTH SYSTEM · PI LANFEAR, DAVID E, SABBAH, HANI N · 2017 to 2020
$3.1M
Henry Ford Research Foundation 0000000NHLBI NIH HHS R01 HL103871NHLBI NIH HHS R01HL103871NHLBI NIH HHS R01 HL132154
6 · The paper itself

Abstract

backgroundElevated resting heart rate (HR) is a risk factor and therapeutic target in patients with heart failure (HF) and reduced ejection fraction (HFrEF). Previous studies indicate a genetic contribution to HR in population samples but there is little data in patients with HFrEF.

methodsPatients who met Framingham criteria for HF and had an ejection fraction < 50% were prospectively enrolled in a genetic HF registry (2007-2015, n = 1060). All participants donated blood for DNA and underwent genome-wide genotyping with additional variants called via imputation. We performed testing of previously identified variant "hits" (43 loci) as well as a genome-wide association (GWAS) of HR, adjusted for race, using Efficient Mixed-Model Association Expedited (EMMAX).

resultsThe cohort was 35% female, 51% African American, and averaged 68 years of age. There was a 2 beats per minute (bpm) difference in HR by race, AA being slightly higher. Among 43 candidate variants, 4 single nucleotide polymorphisms (SNPs) in one gene (GJA1) were significantly associated with HR. In genome-wide testing, one statistically significant association peak was identified on chromosome 22q13, with strongest SNP rs535263906 (p = 3.3 × 10

conclusionsThese data confirm GJA1 association with HR in the setting of HFrEF and identify novel candidate genes for HR in HFrEF patients, particularly CELSR1. These associations should be tested in additional cohorts.

Indexed as

AgedBlack or African AmericanCadherinsChromosomes, Human, Pair 22Cohort StudiesConnexin 43FemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyHeart FailureHeart RateHumansMaleMiddle AgedPolymorphism, Single NucleotideRisk FactorsCadherinsCELSR1 cadherin, humanConnexin 43GJA1 protein, humanAfrican AmericansGeneticsHeart rateSingle nucleotide polymorphisms

Identifiers

PMID31113495
PMCPMC6528282
OpenAlexW2945352804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.